Literature DB >> 9879602

Hepatitis viruses and hepatocellular carcinoma.

M C Kew1.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9879602     DOI: 10.1016/s0923-2516(99)89003-7

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


× No keyword cloud information.
  5 in total

1.  The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.

Authors:  S L Feng; Y Guo; V M Factor; S S Thorgeirsson; D W Bell; J R Testa; K A Peifley; J A Winkles
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.

Authors:  Makoto Chuma; Shuhei Hige; Toshiya Kamiyama; Takashi Meguro; Atsushi Nagasaka; Kazuaki Nakanishi; Yoshiya Yamamoto; Mitsuru Nakanishi; Toshihisa Kohara; Takuya Sho; Keiko Yamamoto; Hiromasa Horimoto; Tomoe Kobayashi; Hideki Yokoo; Michiaki Matsushita; Satoru Todo; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2009-06-25       Impact factor: 7.527

3.  High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.

Authors:  Eung Chang Lee; Seong Hoon Kim; Seung Duk Lee; Hyeongmin Park; Soon-Ae Lee; Sang-Jae Park
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

4.  The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.

Authors:  Liang-He Yu; Nan Li; Shu-Qun Cheng
Journal:  Int J Hepatol       Date:  2011-05-30

5.  Viral hepatitis and hepatocellular carcinoma.

Authors:  Peter P Michielsen; Sven M Francque; Jurgen L van Dongen
Journal:  World J Surg Oncol       Date:  2005-05-20       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.